Please try another search
e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet. The company was incorporated in 2001 and is based in London, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Trevor Mervyn Jones | 80 | 2015 | Independent Non-Executive Chairman |
Paul Burke | - | 2020 | Chair of Scientific Advisory Board |
Ahmad Ali Mortazavi | 51 | 2020 | CEO & Director |
Bill Harte | - | 2020 | Member of Scientific Advisory Board |
John Mattick | - | 2020 | Member of Scientific Advisory Board |
Michael Anthony Bretherton | 68 | 2020 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review